Sridhar Kosaraju - 24 May 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
24 May 2021
Net transactions value
-$241,746
Form type
4
Filing time
26 May 2021, 20:28:22 UTC
Next filing
15 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $64,021 -400 -2.7% $160.05 14,600 24 May 2021 See Footnote F1, F2, F3
transaction TXG Class A Common Stock Sale $112,805 -700 -4.8% $161.15 13,900 24 May 2021 See Footnote F1, F3, F4
transaction TXG Class A Common Stock Sale $48,616 -300 -2.2% $162.05 13,600 24 May 2021 See Footnote F1, F3, F5
transaction TXG Class A Common Stock Sale $16,304 -100 -0.74% $163.04 13,500 24 May 2021 See Footnote F1, F3
holding TXG Class A Common Stock 2,833 24 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust.
F2 This transaction was executed in multiple trades at prices ranging from $159.64 to $160.605. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust").
F4 This transaction was executed in multiple trades at prices ranging from $160.66 to $161.635. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $161.91 to $162.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.